These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31781443)

  • 1. Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.
    Tam EL; Draksharam PL; Park JA; Sidhu GS
    Case Rep Oncol Med; 2019; 2019():4314797. PubMed ID: 31781443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
    Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
    Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
    Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
    Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
    James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
    Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab-induced reversible thrombocytopenia in a patient with adenocarcinoma of colon: rare adverse effect of bevacizumab.
    Kumar J; Bhargava M; Aggarwal S
    Case Rep Oncol Med; 2012; 2012():695430. PubMed ID: 23094167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinotecan-induced immune thrombocytopenia.
    Bozec L; Bierling P; Fromont P; Lévi F; Debat P; Cvitkovic E; Misset JL
    Ann Oncol; 1998 Apr; 9(4):453-5. PubMed ID: 9636839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia.
    Honda S; Tsujimoto M; Minegaki T; Mori T; Muraoka J; Nishiguchi K
    J Clin Pharm Ther; 2020 Apr; 45(2):373-375. PubMed ID: 31671217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies.
    Ohtani H; Arimoto Y; Nishio K; Kanamiya Y; Oba H; Adachi K; Shintani M; Nakamura R; Yui S
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1769-74. PubMed ID: 18931586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of sigmoid colon cancer with liver and ovarian metastases effectively treated by panitumumab after acquiring resistance to prior chemotherapy regimens].
    Honda K; Hata Y; Ihara E; Tomita Y; Miyata S; Sumida Y; Ihara Y; Misawa T
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1533-6. PubMed ID: 21918357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma].
    Zhang T; Su D; Li J; Wang Y; Han C; Jiao S; Bai L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):584-8. PubMed ID: 26108774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOLFIRI as second-line chemotherapy after failure of FOLFOX4 in advanced colorectal cancer: a Korean single-center experience.
    Kim JH; Park SJ; Park MI; Moon W; Kim SE; Ku KH; Song SE; Kim JH
    Korean J Gastroenterol; 2014 Jan; 63(1):18-24. PubMed ID: 24463284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
    Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
    Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of oxaliplatin-induced immune-mediated thrombocytopenia.
    Suh SE; Jang MJ; Chong SY; Aster RH; Curtis BR; Oh D
    Blood Res; 2014 Mar; 49(1):61-4. PubMed ID: 24724069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin-induced immune pancytopenia.
    Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
    Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated pancytopenia induced by oxaliplatin: a case report.
    Fontão-Wendel R; Hoff PM; Lazar A; Freitas D; Novis Y; Patah P; Tsujita M; Balthazar A; Pierroti M; Wendel S
    Transfusion; 2010 Jul; 50(7):1453-9. PubMed ID: 20210930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful management using laparoscopic splenectomy for splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced rectal cancer].
    Koike N; Ohshima Y; Takeuchi T; Arita S; Shinozaki E
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):815-7. PubMed ID: 23863666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.